Table 4 Late toxicities after concurrent chemoradiotherapy for bladder preservation
From: Upper Egypt experience in bladder preservation using concurrent chemoradiotherapy
Late toxicity* | I | II | III | IV | ||||
|---|---|---|---|---|---|---|---|---|
Group A | Group B | Group A | Group B | Group A | Group B | Group A | Group B | |
13.3% | 23.3% | 33.3% | 6.6% | 0% | 3.3% | 0% | 0% | |
53.3% | 23.3% | 13.3% | 13.2% | 0% | 6.6% | 0% | 0% | |
16.6% | 6.6% | 6.6% | 0% | 0% | 0% | 0% | 0% | |
6.6% | 3.3% | 0% | 3.3% | 0% | 0% | 3.3% | 0% | |